76 -11 (61) 2023 — Mirzoyeva M.R., Bakhshilloyeva R.E. — IMPORTANCE OF IMMUNOLOGICAL CHANGES IN VITILIGO DISEASE

IMPORTANCE OF IMMUNOLOGICAL CHANGES IN VITILIGO DISEASE

Mirzoyeva M.R., Bukhara State Medical Institute named after Abu Ali ibn Sina,

Bakhshilloyeva R.E. Bukhara State Medical Institute named after Abu Ali ibn Sina,

Resume
This article covers the results of today’s advances in science about the role of immunological
processes, which are important in vitiligo. Investigations conducted on the identification of cellular
and tissue hormones – cytokines, which participate as promoters of melanocyte apoptosis or
suppressing its activity in the tissue, are studied. The collected data serve as the main source of
information important in the study of the etiopathogenesis of the disease.
Key words: vitiligo, apoptosis, immunopathogenesis, cytokine, oxidative stress

First page

458

Last page

463

For citation: Mirzoyeva M.R., Bakhshilloyeva R.E. – IMPORTANCE OF IMMUNOLOGICAL CHANGES IN VITILIGO DISEASE //New Day in Medicine 2023 11(61): 458-463 https://newdaymedicine.com/index.php/2023/12/24/l-654/

LIST OF REFERENCES:

  1. Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. // Lancet 2015;386:74-84.
    10.1016/S0140-6736(14)60763-7
  2. Frisoli ML, Essien K, Harris JE. Vitiligo: Mechanisms of Pathogenesis and Treatment. // Annu
    Rev Immunol 2020;38:621-48. 10.1146/annurev-immunol-100919-023531
  3. Picardo M, Dell’Anna ML, Ezzedine K, Hamzavi I, Harris JE, Parsad D, et al.. Vitiligo. // Nat
    Rev Dis Primers 2015;1:15011. 10.1038/nrdp.2015.11
  4. Boniface K, Seneschal J, Picardo M, Taïeb A. Vitiligo: Focus on Clinical Aspects,
    Immunopathogenesis, and Therapy. // Clin Rev Allergy Immunol 2018;54:52-67.
    10.1007/s12016-017-8622-7
  5. Van Geel N, Mollet I, Brochez L, Dutré M, De Schepper S, Verhaeghe E, et al.. New Insights in
    Segmental Vitiligo: Case Report and Review of Theories. // Br J Dermatol 2012;166:240-6.
    10.1111/j.1365-2133.2011.10650.x
  6. Boniface K, Seneschal J. Vitiligo as a Skin Memory Disease: The Need for Early Intervention
    With Immunomodulating Agents and a Maintenance Therapy to Target Resident Memory T
    Cells. // Exp Dermatol 2019;28:656-61. 10.1111/exd.13879
  7. Riding RL, Harris JE. The Role of Memory Cd8+ T Cells in Vitiligo. // J
    Immunol 2019;203:11-9. 10.4049/jimmunol.1900027
  8. Seneschal J, Boniface K, D’Arino A, Picardo M. An Update on Vitiligo Pathogenesis. //
    Pigment Cell Melanoma Res 2021;34:236-43. 10.1111/pcmr.12949
  9. Dwivedi M, Kemp EH, Laddha NC, Mansuri MS, Weetman AP, Begum R. Regulatory T Cells
    in Vitiligo: Implications for Pathogenesis and Therapeutics. // Autoimmun Rev 2015;14:49-56.
  10. Mukhatayev Z, Ostapchuk YO, Fang D, Le Poole IC. Engineered Antigen-Specific Regulatory
    T Cells for Autoimmune Skin Conditions. // Autoimmun Rev 2021;20:102761.
  11. Rosmarin D, Pandya AG, Lebwohl M, Grimes P, Hamzavi I, Gottlieb AB, et al. Ruxolitinib
    Cream for Treatment of Vitiligo: A Randomised, Controlled, Phase 2 Trial. // Lancet 2020;
    396:110-20.
  12. Passeron T. First Step in a New Era for Treatment of Patients With
    Vitiligo. Lancet 2020;396:74-5. 10.1016/S0140-6736(20)30747-9
  13. Boniface K, Seneschal J, Picardo M, Taïeb A. Vitiligo: Focus on Clinical
    Aspects, Immunopathogenesis, and Therapy. // Clin Rev Allergy Immunol
    2018;54:52-67. doi: 10.1007/s12016-017-8622-7
  14. Picardo M, Dell’Anna ML, Ezzedine K, Hamzavi I, Harris JE, Parsad D, et al.Vitiligo. // Nat
    Rev Dis Primers 2015;1:15011. doi:10.1038/nrdp.2015.11
  15. Willemsen M, LinkutėR, Luiten RM, Matos TR. Skin-resident memory T cellsas a potential
    new therapeutic target in vitiligo and melanoma. // Pigment CellMelanoma Res 2019;32:612-22.
    doi: 10.1111/pcmr.12803
  16. Riding RL, Harris JE.The Role of Memory CD8+ T Cells in Vitiligo.
    // J Immunol 2019;203:11-9. doi:10.4049/jimmunol.1900027
  17. Roberts GHL, Santorico SA, Spritz RA. The genetic architecture of vitiligo.
    // Pigment Cell Melanoma Res 2020;33:8-15. doi:10.1111/pcmr.12848
  18. Jin Y, Santorico SA, Spritz RA. Pediatric to Adult Shift in Vitiligo Onset
    Suggests Altered Environmental Triggering. // J Invest Dermatol 2020;140:241-243.e4.
    doi:10.1016/j.jid.2019.06.131
  19. Spritz RA, Santorico SA. The Genetic Basis of Vitiligo. // J Invest Dermatol
    2020;41(2):265-73. doi: 10.1016/j.jid.2020.06.004
  20. Jin Y, Andersen G, Yorgov D, Ferrara TM, Ben S, Brownson KM, et al.
    Genetic susceptibility tovitiligo: reсent progress from genome-wideassociation studies //
    Dermatologica Sinica 2014;32:225-232.

file

download